Stock Track | Elanco Animal Health Soars 8.89% in Pre-market Trading After Q2 Earnings Beat and Raised Guidance

Stock Track

Aug 05

Elanco Animal Health Inc (ELAN) shares surged 8.89% in pre-market trading on Wednesday, as investors reacted to the company's second-quarter financial results that handily exceeded Wall Street expectations and an upward revision to its full-year outlook.

The animal-health company reported adjusted earnings per share of $0.34 for the quarter, well above the $0.27 consensus estimate. Revenue climbed 10% year-over-year to $1.37 billion, surpassing the $1.31 billion analysts had forecast. The strong performance was driven by robust demand in the U.S. Pet Health segment, with new products Zenrelia and Credelio Quattro leading the growth.

Elanco also raised its fiscal 2026 revenue guidance to a range of $5.09 billion to $5.14 billion, up from its prior view of $5.01 billion to $5.09 billion, and lifted its adjusted EPS forecast to $1.10–$1.16, compared with the previous $1.03–$1.09. Both ranges topped analysts' estimates, reinforcing confidence in the company's innovation pipeline and pricing power.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/news/1191232145"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1191232145\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1191232145?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-05 21:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1191232145","market":"nz","top_or_hot":-1,"title":"Stock Track | Elanco Animal Health Soars 8.89% in Pre-market Trading After Q2 Earnings Beat and Raised Guidance","media":"Stock Track","content":"<p>Elanco Animal Health Inc (ELAN) shares surged 8.89% in pre-market trading on Wednesday, as investors reacted to the company's second-quarter financial results that handily exceeded Wall Street expectations and an upward revision to its full-year outlook.</p>\n\n<p>The animal-health company reported adjusted earnings per share of $0.34 for the quarter, well above the $0.27 consensus estimate. Revenue climbed 10% year-over-year to $1.37 billion, surpassing the $1.31 billion analysts had forecast. The strong performance was driven by robust demand in the U.S. Pet Health segment, with new products Zenrelia and Credelio Quattro leading the growth.</p>\n\n<p>Elanco also raised its fiscal 2026 revenue guidance to a range of $5.09 billion to $5.14 billion, up from its prior view of $5.01 billion to $5.09 billion, and lifted its adjusted EPS forecast to $1.10–$1.16, compared with the previous $1.03–$1.09. Both ranges topped analysts' estimates, reinforcing confidence in the company's innovation pipeline and pricing power.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Elanco Animal Health Soars 8.89% in Pre-market Trading After Q2 Earnings Beat and Raised Guidance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Elanco Animal Health Soars 8.89% in Pre-market Trading After Q2 Earnings Beat and Raised Guidance\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-08-05 21:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Elanco Animal Health Inc (ELAN) shares surged 8.89% in pre-market trading on Wednesday, as investors reacted to the company's second-quarter financial results that handily exceeded Wall Street expectations and an upward revision to its full-year outlook.</p>\n\n<p>The animal-health company reported adjusted earnings per share of $0.34 for the quarter, well above the $0.27 consensus estimate. Revenue climbed 10% year-over-year to $1.37 billion, surpassing the $1.31 billion analysts had forecast. The strong performance was driven by robust demand in the U.S. Pet Health segment, with new products Zenrelia and Credelio Quattro leading the growth.</p>\n\n<p>Elanco also raised its fiscal 2026 revenue guidance to a range of $5.09 billion to $5.14 billion, up from its prior view of $5.01 billion to $5.09 billion, and lifted its adjusted EPS forecast to $1.10–$1.16, compared with the previous $1.03–$1.09. Both ranges topped analysts' estimates, reinforcing confidence in the company's innovation pipeline and pricing power.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ELAN","symbol_name":"Elanco Animal Health Inc","start_time":0,"source_url":"","article_id":"1191232145","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1191232145","pubTimestamp":1785937371,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Elanco Animal Health Inc (ELAN) shares surged 8.89% in pre-market trading on Wednesday, as investors reacted to the company's second-quarter financial results that handily exceeded Wall Street...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ELAN":"Elanco Animal Health Inc"},"translate_title":"股票跟踪 | Elanco Animal Health 第二季度盈利超出预期并上调指引后，盘前交易中股价飙升 8.89%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ELAN":1},"content_text":"Elanco Animal Health Inc (ELAN) shares surged 8.89% in pre-market trading on Wednesday, as investors reacted to the company's second-quarter financial results that handily exceeded Wall Street expectations and an upward revision to its full-year outlook.\nThe animal-health company reported adjusted earnings per share of $0.34 for the quarter, well above the $0.27 consensus estimate. Revenue climbed 10% year-over-year to $1.37 billion, surpassing the $1.31 billion analysts had forecast. The strong performance was driven by robust demand in the U.S. Pet Health segment, with new products Zenrelia and Credelio Quattro leading the growth.\nElanco also raised its fiscal 2026 revenue guidance to a range of $5.09 billion to $5.14 billion, up from its prior view of $5.01 billion to $5.09 billion, and lifted its adjusted EPS forecast to $1.10–$1.16, compared with the previous $1.03–$1.09. Both ranges topped analysts' estimates, reinforcing confidence in the company's innovation pipeline and pricing power.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"2","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}